Stay updated with breaking news from Ambry Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genetic testing firm Ambry Genetics and Pacific Biosciences of California Inc. are working together to find the genetic cause of rare diseases in pediatric patients.PacBio (Nasdaq: PACB), a biotechnology company in Menlo Park valued at $524 million, manufactures gene sequencing technology for scientists and clinical researchers.
Press release - DataM Intelligence - Age Related Macular Degeneration Market 2024 Highlights on Future Development, Top Trends and Leading Players Analysis to 2031 Bayer, Novartis. - published on openPR.com
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The
Dublin, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The
/PRNewswire/ -- The "Asia-Pacific Multicancer Screening Market - Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering....